Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $282.21 | 13 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $87.88 | 4 | $0 (2023) |
| ABBVIE INC. | $62.92 | 3 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $45.62 | 2 | $0 (2023) |
| Amarin Pharma Inc. | $23.15 | 1 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $22.30 | 1 | $0 (2022) |
| Lilly USA, LLC | $22.30 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $18.04 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $128.98 | 6 | Novartis Pharmaceuticals Corporation ($45.62) |
| 2022 | $118.83 | 5 | Novo Nordisk Inc ($68.58) |
| 2021 | $34.40 | 2 | Amarin Pharma Inc. ($23.15) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/30/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: RESPIRATORY | ||||||
| 05/18/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Diabetes | ||||||
| 04/25/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/05/2023 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $24.89 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.72 | General |
| Category: NEUROSCIENCE | ||||||
| 01/13/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Diabetes | ||||||
| 10/26/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.95 | General |
| Category: NEUROSCIENCE | ||||||
| 08/24/2022 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Diabetes | ||||||
| 08/10/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.30 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/22/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: Diabetes | ||||||
| 04/20/2022 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Diabetes | ||||||
| 09/22/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.25 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $23.15 | General |
| Category: Cardiovascular | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 95 | 211 | $41,225 | $15,409 |
| 2022 | 4 | 131 | 277 | $54,361 | $18,450 |
| 2021 | 5 | 215 | 362 | $73,564 | $28,815 |
| 2020 | 5 | 156 | 287 | $56,682 | $16,352 |
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 156 | $37,276 | $13,650 | 36.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $2,696 | $1,383 | 51.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 17 | 31 | $900.02 | $252.02 | 28.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $353.08 | $124.08 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 84 | 211 | $51,971 | $17,816 | 34.3% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2022 | 17 | 26 | $1,141 | $382.23 | 33.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 14 | 16 | $588.26 | $180.71 | 30.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 16 | 24 | $660.00 | $71.04 | 10.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 107 | 216 | $51,881 | $20,920 | 40.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 58 | 89 | $15,050 | $5,513 | 36.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 15 | 15 | $4,999 | $1,807 | 36.1% |
| 99211 | Established patient outpatient visit, minimal presenting problem | Office | 2021 | 24 | 31 | $1,304 | $541.80 | 41.5% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 11 | 11 | $330.00 | $33.00 | 10.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 93 | 220 | $40,245 | $11,559 | 28.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 21 | 21 | $6,104 | $2,413 | 39.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 18 | 22 | $5,923 | $1,164 | 19.7% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 11 | 11 | $2,996 | $779.72 | 26.0% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 13 | 13 | $1,414 | $436.32 | 30.9% |
About Dr. George Macris, MD
Dr. George Macris, MD is a Emergency Medicine healthcare provider based in Dededo, Guam. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/27/2011. The National Provider Identifier (NPI) number assigned to this provider is 1336445055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. George Macris, MD has received a total of $282.21 in payments from pharmaceutical and medical device companies, with $128.98 received in 2023. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($282.21).
As a Medicare-enrolled provider, Macris has provided services to 597 Medicare beneficiaries, totaling 1,137 services with total Medicare billing of $79,026. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine, Emergency Medicine
- Location Dededo, GU
- Active Since 01/27/2011
- Last Updated 05/16/2011
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1336445055
Products in Payments
- Rybelsus (Drug) $66.70
- VRAYLAR (Drug) $62.92
- ENTRESTO (Drug) $24.89
- Vascepa (Drug) $23.15
- FARXIGA (Drug) $22.30
- MOUNJARO (Drug) $22.30
- Ozempic (Drug) $21.18
- LEQVIO (Drug) $20.73
- TRELEGY ELLIPTA (Drug) $18.04
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Dededo
Anthony Bekkerman, M.d, M.D
Emergency Medicine — Payments: $188.94
Kathryn Guffrey, M.d, M.D
Emergency Medicine — Payments: $38.08
Brian Harris, M.d, M.D
Emergency Medicine — Payments: $33.34
Dr. Lawrence Lee, D.o, D.O
Emergency Medicine — Payments: $20.36
Sarah Haley-Wien, D.o, D.O
Emergency Medicine
Amanda River, M.d., M.p.h, M.D., M.P.H
Emergency Medicine